Letter to the editor regarding ‘perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection’

Click to increase image sizeClick to decrease image size

Acknowledgments

Editorial support was provided by Leslie Mitchell, PhD, and Melanie Styers, PhD, of BluPrint Oncology Concepts, LLC.

Declaration of Interests

S Dalai discloses employment and equity interest in Adaptive Biotechnologies. L Baldo discloses leadership, employment, and equity interest in Adaptive Biotechnologies. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Editor disclosures

The editor that approved this manuscript for publication has no relevant financial relationships or otherwise to disclose.

Additional information

Funding

This letter is funded by Adaptive Biotechnologies.